- 1. atomic absorption spectrometry
- [spectrophotometric techniques in which the samples are examined in the form of atoms based on their unique energy levels for electrons; particularly used to analyze trace elements. ( CSP )] (UMLS (CSP) C0037806) =Laboratory Procedure ;
=spectrometry;
ObservationMethod | - 7. ATONY OF BLADDER
- (UMLS (ICD9CM) C0403645) =Finding
|
- 2. atomic energy
- [Energy released by nuclear fission or nuclear fusion. ( MSH )] (UMLS (CSP) C0028572) =Natural Phenomenon or Process ;
| - 8. Atopic Allergy
- [genetic predisposition toward the development of immediate (type I) hypersensitivity reactions against common environmental antigens (atopic allergy); the most common clinical manifestation is allergic rhinitis; bronchial asthmas, atopic dermatitis and food allergy also occur. ( CSP )] (UMLS (NCI) C0392707) =Pathologic Function =Allergy;
=ARNASESTUA;
allergic dermatitis;
Allergic rhinitis due to pollen |
- 3. atomic orbital
- [ ] (UMLS (CSP) C0598889) =Qualitative Concept ;
| - 9. Atopic dermatitis and related conditions
- (UMLS (ICD9CM) C0004187) =Disease or Syndrome ;
|
- 4. Atomic service/test/observation (test code or treatment code)
- (UMLS (HL7) C1549572) =Idea or Concept =Nature of Service/Test/Observation;
| - 10. Atopic dermatitis/eczema
- (UMLS (ICPC) C0497391) (Atopic dermatitis/eczema; DERMATITI ATOPIKOA; Atopisk dermatit/eksem; Constitutioneel eczeem; ATOOPPINEN IHOTTUMA/EKSEEMA; Dermatite atopique/eczema; Dermatitis atopica/chron Ekzem; atopik dermatitis/ekzema; atopias dermatitis/eccema; Dermatite atopica/eczema; EKSEM/ATOPISK DERMATITT; Dermatite/eczema atopico; Dermatitis atopica/eccema; ATOPISKT UTSLAG/EKSEM) =Disease or Syndrome ;
=Diagnosis/Diseases Component; Integument |
- 5. Atonic Epilepsy
- (UMLS (NCI) C0086236) =Disease or Syndrome ;
| - 11. Atorvastatin Calcium
- [The calcium salt form of atorvastatin, a synthetic lipid-lowering agent. Atorvastatin competitively inhibits hepatic hydroxymethyl-glutaryl coenzyme A (HMG-CoA) reductase, the enzyme which catalyzes the conversion of HMG-CoA to mevalonate, a key step in cholesterol synthesis. Atorvastatin also increases the number of LDL receptors on hepatic cell surfaces to enhance uptake and catabolism of LDL and reduces LDL production and the number of LDL particles. This agent lowers plasma cholesterol and lipoprotein levels and modulates immune responses by suppressing MHC II (major histocompatibility complex II) on interferon gamma-stimulated, antigen-presenting cells such as human vascular endothelial cells. (NCI04) ( NCI )] (UMLS (NCI) C0286650) =Organic Chemical; Pharmacologic Substance =(betaR,deltaR)-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid;
=atorvastatin 10 MG;
atorvastatin 20 MG;
ATORVASTATIN CALCIUM 80 MG;
atorvastatin 40 MG;
|
- 6. atonic seizure
- [ ] (UMLS (CSP) C0270846) =Disease or Syndrome
| - 12. ATOVAQUONE
- [broad-spectrum antiparasitic drug found to be active against Pneumocystis carinii pneumonia in AIDS patients. ( CSP )] (UMLS (NCI) C0165603) =Organic Chemical; Pharmacologic Substance =[AM700] ANTIFUNGALS;
[AP000] ANTIPARASITICS;
Antiprotozoal Agent;
naphthoquinone;
[AP109] ANTIPROTOZOALS, OTHER;
=Atovaquone 150 MG/ML;
ATOVAQUONE 250 MG;
ATOVAQUONE 62.5 MG |
home
